188 related articles for article (PubMed ID: 1983489)
21. [Should adjuvant or neoadjuvant treatment be administered in esophageal cancer?].
Bedenne L
Ann Chir; 1997; 51(6):605-10. PubMed ID: 9406457
[TBL] [Abstract][Full Text] [Related]
22. [Neoadjuvant chemoradiotherapy for advanced squamous cell carcinoma of thoracic esophagus].
Takahashi S; Sato Y; Kondo M; Kudo T; Shimokuni T; Maeda Y; Honnma S; Shinohara T; Kohashi S; Todo S
Gan To Kagaku Ryoho; 2004 Jan; 31(1):45-9. PubMed ID: 14750320
[TBL] [Abstract][Full Text] [Related]
23. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
[TBL] [Abstract][Full Text] [Related]
24. Post-operative chemotherapy improves disease-free survival, but not overall survival in people with oesophageal squamous cell carcinoma.
Leonard GD; Reilly EM
Cancer Treat Rev; 2004 Aug; 30(5):473-7. PubMed ID: 15245779
[No Abstract] [Full Text] [Related]
25. Neoadjuvant chemotherapy with etoposide, leucovorin, 5-fluorouracil and cisplatin for advanced esophageal squamous cell carcinoma.
Ohwada S; Nakamura S; Izumi M; Kawashima Y; Ogawa T; Kobayashi I; Hosomura Y; Joshita T; Lino Y; Morishita Y
Jpn J Clin Oncol; 1995 Jun; 25(3):79-85. PubMed ID: 7596052
[TBL] [Abstract][Full Text] [Related]
26. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
Elsaleh H; Farrell JJ; Crane CH
J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
[No Abstract] [Full Text] [Related]
27. [A case report of esophageal carcinoma with grade 3 response by preoperative chemotherapy using CDDP/5-FU/LV].
Bando K; Onda M; Miyashita M; Takahashi Y; Takita M; Matsutani T; Okawa K; Sasajima K; Ujihara Y; Takubo K; Yamashita K
Gan To Kagaku Ryoho; 1998 May; 25(6):915-8. PubMed ID: 9617331
[TBL] [Abstract][Full Text] [Related]
28. Combined chemotherapy and radiotherapy followed by surgery in the treatment of patients with squamous cell carcinoma of the esophagus.
Adham M; Baulieux J; Mornex F; de La Roche de Bransat E; Ducerf C; Souquet JC; Gerard JP
Cancer; 2000 Sep; 89(5):946-54. PubMed ID: 10964323
[TBL] [Abstract][Full Text] [Related]
29. Clinical markers of hypoxia and other predictive factors of survival in conservative therapy of squamous-cell carcinoma of the esophagus.
Taussky D; Rousson V; Pescia R
Int J Colorectal Dis; 2003 Mar; 18(2):167-71. PubMed ID: 12548421
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of epidermoid cancer of the esophagus].
Elias D; Lasser P; Eschwege F; Zummer K; Nitenberg G; Leclercq B; Kac J; Rougier P
Ann Chir; 1984 Apr; 38(3):234-45. PubMed ID: 6375535
[No Abstract] [Full Text] [Related]
31. [Multimodality treatment of esophageal carcinoma: evaluation of preoperative (neoadjuvant) chemotherapy].
Nagai K; Endoh M
Gan To Kagaku Ryoho; 1993 Jul; 20(9):1154-60. PubMed ID: 8333743
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant therapy of esophageal cancer.
Ilson DH; Bains M; Ginsberg RJ; Kelsen DP
Surg Oncol Clin N Am; 1997 Oct; 6(4):723-40. PubMed ID: 9309090
[TBL] [Abstract][Full Text] [Related]
33. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
[TBL] [Abstract][Full Text] [Related]
34. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
35. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone.
Ancona E; Ruol A; Santi S; Merigliano S; Sileni VC; Koussis H; Zaninotto G; Bonavina L; Peracchia A
Cancer; 2001 Jun; 91(11):2165-74. PubMed ID: 11391598
[TBL] [Abstract][Full Text] [Related]
36. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer.
Sujendran V; Wheeler J; Baron R; Warren BF; Maynard N
Br J Surg; 2008 Feb; 95(2):191-4. PubMed ID: 17948302
[TBL] [Abstract][Full Text] [Related]
37. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
Yano T; Muto M; Hattori S; Minashi K; Onozawa M; Nihei K; Ishikura S; Ohtsu A; Yoshida S
Endoscopy; 2008 Sep; 40(9):717-21. PubMed ID: 18773340
[TBL] [Abstract][Full Text] [Related]
38. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
Nakamori M; Iwahashi M; Nakamura M; Yamaue H
J Surg Oncol; 2003 Sep; 84(1):10-6. PubMed ID: 12949985
[TBL] [Abstract][Full Text] [Related]
39. Preoperative concurrent chemotherapy and radiation therapy followed by surgery for esophageal cancer.
Yano M; Inoue M; Shiozaki H
Ann Thorac Cardiovasc Surg; 2002 Jun; 8(3):123-30. PubMed ID: 12472392
[TBL] [Abstract][Full Text] [Related]
40. [Value of radiotherapy and chemotherapy in treatment of operable cancers of the esophagus].
Msika S; Hay JM
J Chir (Paris); 2002 Feb; 139(1):17-24. PubMed ID: 12071024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]